ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7N15613
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global GLP 1 Drug Market Research Report 2023
BUY CHAPTERS

Global GLP-1 Drug Market Research Report 2025

Code: QYRE-Auto-7N15613
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Pfizer Inc
Novo Nordisk
GlaxoSmithKline(GSK )
Gan & Lee Pharmaceuticals
Tonghua Dongbao
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Astrazeneca plc
Eli Lilly
Boehringer Ingelheim
Hanmi Pharmaceutical Co
Teva Pharmaceutical Industries Ltd
Huadong Medicine
Shanghai Benemae Pharmaceutical Corporation
PegBio Co., Ltd

GLP-1 Drug Market Size

The global market for GLP-1 Drug was valued at US$ 31190 million in the year 2024 and is projected to reach a revised size of US$ 151520 million by 2031, growing at a CAGR of 25.7% during the forecast period.

GLP-1 Drug Market

GLP-1 Drug Market

North American market for GLP-1 Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for GLP-1 Drug is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of GLP-1 Drug include Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Hanmi Pharmaceutical Co, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, GlaxoSmithKline (GSK), Huadong Medicine, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1 Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Drug.
The GLP-1 Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the GLP-1 Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of GLP-1 Drug Market Report

Report Metric Details
Report Name GLP-1 Drug Market
Accounted market size in year US$ 31190 million
Forecasted market size in 2031 US$ 151520 million
CAGR 25.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Short-acting GLP-1 Drug
  • Long-acting GLP-1 Drug
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Hanmi Pharmaceutical Co, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, GlaxoSmithKline (GSK), Huadong Medicine, Gan & Lee Pharmaceuticals, Tonghua Dongbao, Shanghai Benemae Pharmaceutical Corporation, Jiangsu Hansoh Pharmaceutical Group Co., Ltd., PegBio Co., Ltd
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of GLP-1 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of GLP-1 Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is GLP-1 Drug Market growing?

Ans: The GLP-1 Drug Market witnessing a CAGR of 25.7% during the forecast period 2025-2031.

What is the GLP-1 Drug Market size in 2031?

Ans: The GLP-1 Drug Market size in 2031 will be US$ 151520 million.

Who are the main players in the GLP-1 Drug Market report?

Ans: The main players in the GLP-1 Drug Market are Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Hanmi Pharmaceutical Co, Teva Pharmaceutical Industries Ltd, Boehringer Ingelheim, GlaxoSmithKline (GSK), Huadong Medicine, Gan & Lee Pharmaceuticals, Tonghua Dongbao, Shanghai Benemae Pharmaceutical Corporation, Jiangsu Hansoh Pharmaceutical Group Co., Ltd., PegBio Co., Ltd

What are the Application segmentation covered in the GLP-1 Drug Market report?

Ans: The Applications covered in the GLP-1 Drug Market report are Obesity, Type 2 Diabetes (T2DM), Cardiovascular and Cerebrovascular Diseases (CVD), Non-alcoholic Steatohepatitis (NASH), Alzheimer's Disease (AD)

What are the Type segmentation covered in the GLP-1 Drug Market report?

Ans: The Types covered in the GLP-1 Drug Market report are Short-acting GLP-1 Drug, Long-acting GLP-1 Drug

Recommended Reports

Diabetes Drug Markets

Obesity Treatment Markets

GLP-1 Related Reports

1 GLP-1 Drug Market Overview
1.1 Product Definition
1.2 GLP-1 Drug by Type
1.2.1 Global GLP-1 Drug Market Value Comparison by Type (2024 VS 2031)
1.2.2 Short-acting GLP-1 Drug
1.2.3 Long-acting GLP-1 Drug
1.3 GLP-1 Drug by Application
1.3.1 Global GLP-1 Drug Market Value by Application (2024 VS 2031)
1.3.2 Obesity
1.3.3 Type 2 Diabetes (T2DM)
1.3.4 Cardiovascular and Cerebrovascular Diseases (CVD)
1.3.5 Non-alcoholic Steatohepatitis (NASH)
1.3.6 Alzheimer's Disease (AD)
1.4 Global GLP-1 Drug Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Drug Revenue 2020-2031
1.4.2 Global GLP-1 Drug Sales 2020-2031
1.4.3 Global GLP-1 Drug Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 GLP-1 Drug Market Competition by Manufacturers
2.1 Global GLP-1 Drug Sales Market Share by Manufacturers (2020-2025)
2.2 Global GLP-1 Drug Revenue Market Share by Manufacturers (2020-2025)
2.3 Global GLP-1 Drug Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of GLP-1 Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of GLP-1 Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of GLP-1 Drug, Product Type & Application
2.7 Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
2.8 Global GLP-1 Drug Market Competitive Situation and Trends
2.8.1 Global GLP-1 Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest GLP-1 Drug Players Market Share by Revenue
2.8.3 Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Drug Market Scenario by Region
3.1 Global GLP-1 Drug Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global GLP-1 Drug Sales by Region: 2020-2031
3.2.1 Global GLP-1 Drug Sales by Region: 2020-2025
3.2.2 Global GLP-1 Drug Sales by Region: 2026-2031
3.3 Global GLP-1 Drug Revenue by Region: 2020-2031
3.3.1 Global GLP-1 Drug Revenue by Region: 2020-2025
3.3.2 Global GLP-1 Drug Revenue by Region: 2026-2031
3.4 North America GLP-1 Drug Market Facts & Figures by Country
3.4.1 North America GLP-1 Drug Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America GLP-1 Drug Sales by Country (2020-2031)
3.4.3 North America GLP-1 Drug Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Drug Market Facts & Figures by Country
3.5.1 Europe GLP-1 Drug Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe GLP-1 Drug Sales by Country (2020-2031)
3.5.3 Europe GLP-1 Drug Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Drug Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Drug Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific GLP-1 Drug Sales by Region (2020-2031)
3.6.3 Asia Pacific GLP-1 Drug Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Drug Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Drug Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America GLP-1 Drug Sales by Country (2020-2031)
3.7.3 Latin America GLP-1 Drug Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Drug Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa GLP-1 Drug Sales by Country (2020-2031)
3.8.3 Middle East and Africa GLP-1 Drug Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Drug Sales by Type (2020-2031)
4.1.1 Global GLP-1 Drug Sales by Type (2020-2025)
4.1.2 Global GLP-1 Drug Sales by Type (2026-2031)
4.1.3 Global GLP-1 Drug Sales Market Share by Type (2020-2031)
4.2 Global GLP-1 Drug Revenue by Type (2020-2031)
4.2.1 Global GLP-1 Drug Revenue by Type (2020-2025)
4.2.2 Global GLP-1 Drug Revenue by Type (2026-2031)
4.2.3 Global GLP-1 Drug Revenue Market Share by Type (2020-2031)
4.3 Global GLP-1 Drug Price by Type (2020-2031)
5 Segment by Application
5.1 Global GLP-1 Drug Sales by Application (2020-2031)
5.1.1 Global GLP-1 Drug Sales by Application (2020-2025)
5.1.2 Global GLP-1 Drug Sales by Application (2026-2031)
5.1.3 Global GLP-1 Drug Sales Market Share by Application (2020-2031)
5.2 Global GLP-1 Drug Revenue by Application (2020-2031)
5.2.1 Global GLP-1 Drug Revenue by Application (2020-2025)
5.2.2 Global GLP-1 Drug Revenue by Application (2026-2031)
5.2.3 Global GLP-1 Drug Revenue Market Share by Application (2020-2031)
5.3 Global GLP-1 Drug Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novo Nordisk GLP-1 Drug Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lilly GLP-1 Drug Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca GLP-1 Drug Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Company Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sanofi GLP-1 Drug Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Pfizer Inc
6.5.1 Pfizer Inc Company Information
6.5.2 Pfizer Inc Description and Business Overview
6.5.3 Pfizer Inc GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Pfizer Inc GLP-1 Drug Product Portfolio
6.5.5 Pfizer Inc Recent Developments/Updates
6.6 Hanmi Pharmaceutical Co
6.6.1 Hanmi Pharmaceutical Co Company Information
6.6.2 Hanmi Pharmaceutical Co Description and Business Overview
6.6.3 Hanmi Pharmaceutical Co GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Hanmi Pharmaceutical Co GLP-1 Drug Product Portfolio
6.6.5 Hanmi Pharmaceutical Co Recent Developments/Updates
6.7 Teva Pharmaceutical Industries Ltd
6.7.1 Teva Pharmaceutical Industries Ltd Company Information
6.7.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.7.3 Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Teva Pharmaceutical Industries Ltd GLP-1 Drug Product Portfolio
6.7.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.8 Boehringer Ingelheim
6.8.1 Boehringer Ingelheim Company Information
6.8.2 Boehringer Ingelheim Description and Business Overview
6.8.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Boehringer Ingelheim GLP-1 Drug Product Portfolio
6.8.5 Boehringer Ingelheim Recent Developments/Updates
6.9 GlaxoSmithKline (GSK)
6.9.1 GlaxoSmithKline (GSK) Company Information
6.9.2 GlaxoSmithKline (GSK) Description and Business Overview
6.9.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GlaxoSmithKline (GSK) GLP-1 Drug Product Portfolio
6.9.5 GlaxoSmithKline (GSK) Recent Developments/Updates
6.10 Huadong Medicine
6.10.1 Huadong Medicine Company Information
6.10.2 Huadong Medicine Description and Business Overview
6.10.3 Huadong Medicine GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Huadong Medicine GLP-1 Drug Product Portfolio
6.10.5 Huadong Medicine Recent Developments/Updates
6.11 Gan & Lee Pharmaceuticals
6.11.1 Gan & Lee Pharmaceuticals Company Information
6.11.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.11.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Gan & Lee Pharmaceuticals GLP-1 Drug Product Portfolio
6.11.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.12 Tonghua Dongbao
6.12.1 Tonghua Dongbao Company Information
6.12.2 Tonghua Dongbao Description and Business Overview
6.12.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Tonghua Dongbao GLP-1 Drug Product Portfolio
6.12.5 Tonghua Dongbao Recent Developments/Updates
6.13 Shanghai Benemae Pharmaceutical Corporation
6.13.1 Shanghai Benemae Pharmaceutical Corporation Company Information
6.13.2 Shanghai Benemae Pharmaceutical Corporation Description and Business Overview
6.13.3 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product Portfolio
6.13.5 Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
6.14 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
6.14.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
6.14.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Business Overview
6.14.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product Portfolio
6.14.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.15 PegBio Co., Ltd
6.15.1 PegBio Co., Ltd Company Information
6.15.2 PegBio Co., Ltd Description and Business Overview
6.15.3 PegBio Co., Ltd GLP-1 Drug Sales, Revenue and Gross Margin (2020-2025)
6.15.4 PegBio Co., Ltd GLP-1 Drug Product Portfolio
6.15.5 PegBio Co., Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Drug Industry Chain Analysis
7.2 GLP-1 Drug Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Drug Production Mode & Process Analysis
7.4 GLP-1 Drug Sales and Marketing
7.4.1 GLP-1 Drug Sales Channels
7.4.2 GLP-1 Drug Distributors
7.5 GLP-1 Drug Customer Analysis
8 GLP-1 Drug Market Dynamics
8.1 GLP-1 Drug Industry Trends
8.2 GLP-1 Drug Market Drivers
8.3 GLP-1 Drug Market Challenges
8.4 GLP-1 Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Pfizer Inc
Novo Nordisk
GlaxoSmithKline(GSK )
Gan & Lee Pharmaceuticals
Tonghua Dongbao
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Astrazeneca plc
Eli Lilly
Boehringer Ingelheim
Hanmi Pharmaceutical Co
Teva Pharmaceutical Industries Ltd
Huadong Medicine
Shanghai Benemae Pharmaceutical Corporation
PegBio Co., Ltd
List of Tables
 Table 1. Global GLP-1 Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global GLP-1 Drug Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global GLP-1 Drug Market Competitive Situation by Manufacturers in 2024
 Table 4. Global GLP-1 Drug Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global GLP-1 Drug Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global GLP-1 Drug Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global GLP-1 Drug Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market GLP-1 Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of GLP-1 Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of GLP-1 Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of GLP-1 Drug, Product Type & Application
 Table 12. Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Drug as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global GLP-1 Drug Sales by Region (2020-2025) & (K Units)
 Table 18. Global GLP-1 Drug Sales Market Share by Region (2020-2025)
 Table 19. Global GLP-1 Drug Sales by Region (2026-2031) & (K Units)
 Table 20. Global GLP-1 Drug Sales Market Share by Region (2026-2031)
 Table 21. Global GLP-1 Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global GLP-1 Drug Revenue Market Share by Region (2020-2025)
 Table 23. Global GLP-1 Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global GLP-1 Drug Revenue Market Share by Region (2026-2031)
 Table 25. North America GLP-1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America GLP-1 Drug Sales by Country (2020-2025) & (K Units)
 Table 27. North America GLP-1 Drug Sales by Country (2026-2031) & (K Units)
 Table 28. North America GLP-1 Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America GLP-1 Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe GLP-1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe GLP-1 Drug Sales by Country (2020-2025) & (K Units)
 Table 32. Europe GLP-1 Drug Sales by Country (2026-2031) & (K Units)
 Table 33. Europe GLP-1 Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe GLP-1 Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific GLP-1 Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific GLP-1 Drug Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific GLP-1 Drug Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific GLP-1 Drug Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific GLP-1 Drug Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America GLP-1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America GLP-1 Drug Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America GLP-1 Drug Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America GLP-1 Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America GLP-1 Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa GLP-1 Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa GLP-1 Drug Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa GLP-1 Drug Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa GLP-1 Drug Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa GLP-1 Drug Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global GLP-1 Drug Sales (K Units) by Type (2020-2025)
 Table 51. Global GLP-1 Drug Sales (K Units) by Type (2026-2031)
 Table 52. Global GLP-1 Drug Sales Market Share by Type (2020-2025)
 Table 53. Global GLP-1 Drug Sales Market Share by Type (2026-2031)
 Table 54. Global GLP-1 Drug Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global GLP-1 Drug Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global GLP-1 Drug Revenue Market Share by Type (2020-2025)
 Table 57. Global GLP-1 Drug Revenue Market Share by Type (2026-2031)
 Table 58. Global GLP-1 Drug Price (US$/Unit) by Type (2020-2025)
 Table 59. Global GLP-1 Drug Price (US$/Unit) by Type (2026-2031)
 Table 60. Global GLP-1 Drug Sales (K Units) by Application (2020-2025)
 Table 61. Global GLP-1 Drug Sales (K Units) by Application (2026-2031)
 Table 62. Global GLP-1 Drug Sales Market Share by Application (2020-2025)
 Table 63. Global GLP-1 Drug Sales Market Share by Application (2026-2031)
 Table 64. Global GLP-1 Drug Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global GLP-1 Drug Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global GLP-1 Drug Revenue Market Share by Application (2020-2025)
 Table 67. Global GLP-1 Drug Revenue Market Share by Application (2026-2031)
 Table 68. Global GLP-1 Drug Price (US$/Unit) by Application (2020-2025)
 Table 69. Global GLP-1 Drug Price (US$/Unit) by Application (2026-2031)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Novo Nordisk GLP-1 Drug Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lilly GLP-1 Drug Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca GLP-1 Drug Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Sanofi Company Information
 Table 86. Sanofi Description and Business Overview
 Table 87. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sanofi GLP-1 Drug Product
 Table 89. Sanofi Recent Developments/Updates
 Table 90. Pfizer Inc Company Information
 Table 91. Pfizer Inc Description and Business Overview
 Table 92. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Pfizer Inc GLP-1 Drug Product
 Table 94. Pfizer Inc Recent Developments/Updates
 Table 95. Hanmi Pharmaceutical Co Company Information
 Table 96. Hanmi Pharmaceutical Co Description and Business Overview
 Table 97. Hanmi Pharmaceutical Co GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Hanmi Pharmaceutical Co GLP-1 Drug Product
 Table 99. Hanmi Pharmaceutical Co Recent Developments/Updates
 Table 100. Teva Pharmaceutical Industries Ltd Company Information
 Table 101. Teva Pharmaceutical Industries Ltd Description and Business Overview
 Table 102. Teva Pharmaceutical Industries Ltd GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Teva Pharmaceutical Industries Ltd GLP-1 Drug Product
 Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
 Table 105. Boehringer Ingelheim Company Information
 Table 106. Boehringer Ingelheim Description and Business Overview
 Table 107. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Boehringer Ingelheim GLP-1 Drug Product
 Table 109. Boehringer Ingelheim Recent Developments/Updates
 Table 110. GlaxoSmithKline (GSK) Company Information
 Table 111. GlaxoSmithKline (GSK) Description and Business Overview
 Table 112. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. GlaxoSmithKline (GSK) GLP-1 Drug Product
 Table 114. GlaxoSmithKline (GSK) Recent Developments/Updates
 Table 115. Huadong Medicine Company Information
 Table 116. Huadong Medicine Description and Business Overview
 Table 117. Huadong Medicine GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Huadong Medicine GLP-1 Drug Product
 Table 119. Huadong Medicine Recent Developments/Updates
 Table 120. Gan & Lee Pharmaceuticals Company Information
 Table 121. Gan & Lee Pharmaceuticals Description and Business Overview
 Table 122. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Gan & Lee Pharmaceuticals GLP-1 Drug Product
 Table 124. Gan & Lee Pharmaceuticals Recent Developments/Updates
 Table 125. Tonghua Dongbao Company Information
 Table 126. Tonghua Dongbao Description and Business Overview
 Table 127. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Tonghua Dongbao GLP-1 Drug Product
 Table 129. Tonghua Dongbao Recent Developments/Updates
 Table 130. Shanghai Benemae Pharmaceutical Corporation Company Information
 Table 131. Shanghai Benemae Pharmaceutical Corporation Description and Business Overview
 Table 132. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shanghai Benemae Pharmaceutical Corporation GLP-1 Drug Product
 Table 134. Shanghai Benemae Pharmaceutical Corporation Recent Developments/Updates
 Table 135. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
 Table 136. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 137. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product
 Table 139. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 140. PegBio Co., Ltd Company Information
 Table 141. PegBio Co., Ltd Description and Business Overview
 Table 142. PegBio Co., Ltd GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. PegBio Co., Ltd GLP-1 Drug Product
 Table 144. PegBio Co., Ltd Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. GLP-1 Drug Distributors List
 Table 148. GLP-1 Drug Customers List
 Table 149. GLP-1 Drug Market Trends
 Table 150. GLP-1 Drug Market Drivers
 Table 151. GLP-1 Drug Market Challenges
 Table 152. GLP-1 Drug Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 Drug
 Figure 2. Global GLP-1 Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global GLP-1 Drug Market Share by Type: 2024 & 2031
 Figure 4. Short-acting GLP-1 Drug Product Picture
 Figure 5. Long-acting GLP-1 Drug Product Picture
 Figure 6. Global GLP-1 Drug Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global GLP-1 Drug Market Share by Application: 2024 & 2031
 Figure 8. Obesity
 Figure 9. Type 2 Diabetes (T2DM)
 Figure 10. Cardiovascular and Cerebrovascular Diseases (CVD)
 Figure 11. Non-alcoholic Steatohepatitis (NASH)
 Figure 12. Alzheimer's Disease (AD)
 Figure 13. Global GLP-1 Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global GLP-1 Drug Market Size (2020-2031) & (US$ Million)
 Figure 15. Global GLP-1 Drug Sales (2020-2031) & (K Units)
 Figure 16. Global GLP-1 Drug Average Price (US$/Unit) & (2020-2031)
 Figure 17. GLP-1 Drug Report Years Considered
 Figure 18. GLP-1 Drug Sales Share by Manufacturers in 2024
 Figure 19. Global GLP-1 Drug Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest GLP-1 Drug Players: Market Share by Revenue in GLP-1 Drug in 2024
 Figure 21. GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global GLP-1 Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America GLP-1 Drug Sales Market Share by Country (2020-2031)
 Figure 24. North America GLP-1 Drug Revenue Market Share by Country (2020-2031)
 Figure 25. United States GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe GLP-1 Drug Sales Market Share by Country (2020-2031)
 Figure 28. Europe GLP-1 Drug Revenue Market Share by Country (2020-2031)
 Figure 29. Germany GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific GLP-1 Drug Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific GLP-1 Drug Revenue Market Share by Region (2020-2031)
 Figure 36. China GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America GLP-1 Drug Sales Market Share by Country (2020-2031)
 Figure 44. Latin America GLP-1 Drug Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa GLP-1 Drug Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa GLP-1 Drug Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE GLP-1 Drug Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of GLP-1 Drug by Type (2020-2031)
 Figure 55. Global Revenue Market Share of GLP-1 Drug by Type (2020-2031)
 Figure 56. Global GLP-1 Drug Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of GLP-1 Drug by Application (2020-2031)
 Figure 58. Global Revenue Market Share of GLP-1 Drug by Application (2020-2031)
 Figure 59. Global GLP-1 Drug Price (US$/Unit) by Application (2020-2031)
 Figure 60. GLP-1 Drug Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

GLP 1RA Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liraglutide Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global GLP 1R Agonist Market Insights Forecast to 2030
Global Sitagliptin Tablet Market Research Report 2025
Global GLP 1 Receptor Agonists Market Insights Forecast to 2030
Incretin Based Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Incretin Mimetics Market Insights Forecast to 2030
Global Oral Glucose Market Research Report 2025
Global Galaxolide Market Research Report 2024
Global Saxagliptin Market Research Report 2025
Global Eubiotics Market Research Report 2025
Global Glycinate Market Research Report 2024
Global Prebiotic Ingredients Market Research Report 2024
Oral Hypoglycemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glycolipids Market Research Report 2025
Global Insulin Consumables Market Research Report 2024
Saxagliptin Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucagon like Peptide 1 Receptor Agonist Market Insights Forecast to 2030
Global Glucagon Like Peptide 2 Receptor Market Research Report 2024
Global Oral Peptide Therapeutics Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions